Stephanie Wyttenbach
Nurse Practitioner · Denver, CONPI 1588134894
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 321 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 42 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 321 payments — averaging $20.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$616
- Novo Nordisk$543
- Amgen$484
- AstraZeneca$415
- Pfizer$379
- plus $3K from 36 others
What the payments were for
- Food & beverage$6,643100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,654 in reported general payments places this provider in the 95th percentile of 1,384 nurse practitioner providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $24,920 |
| SynthroidLevothyroxine Sodium | 15 | $1,863 |
| Rosuvastatin Calcium | 125 | $1,378 |
| Valsartan | 23 | $755 |
| Losartan Potassium | 48 | $576 |
| Propranolol Hcl ErPropranolol Hcl | 12 | $556 |
| Levothyroxine Sodium | 53 | $474 |
| Pantoprazole Sodium | 26 | $465 |
| Escitalopram Oxalate | 23 | $429 |
| Sertraline Hcl | 35 | $351 |
| Allopurinol | 11 | $323 |
| Amlodipine Besylate | 28 | $280 |
| Atorvastatin Calcium | 39 | $230 |
| Gabapentin | 11 | $227 |
| Ipratropium Bromide | 22 | $197 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $379 | $24,92016 claims |
| AbbVieSynthroid | $1,003 | $1,86315 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $200 | $47453 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,384 nurse practitioner providers in Colorado.
Other nurse practitioner in Denver
- Christina ProulxDenver$28K
- Jose Diaz LeoDenver$24K
- Lolanda McBrideDenver$20K
- Cori FratelliDenver$15K
- Leslie HindsDenver$9K
- Rebecca AndrieDenver$8K
- Nahid Kuseh Kalani YazdDenver$8K
- Amber Whitton-SmithDenver$7K
- Jacqueline CarboneDenver$7K
- Dana HammondsDenver$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.